[Drug Name] : Huangusu
[Chinese Pinyin] HUANGUSU
[Ingredient] Energy protease immune factor extracted from Stethacanthus, huangusu extracted from rhea, achyranthes, deerhorn glue, rhizoma cibotii, tuberculate speranskia herb and bombyx batryticatus, active peptide extracted from sansevieria, blue algae and aloe, saffron, Chinese taxillus twig, doubleteeth rubescent angelica root, eucommia bark, lignum millettiae, red sage root, radix rehmanniae, red paeony root. Etc.
[Functions and Indications] Nourishing kidney, strengthening bones, promoting blood circulation by removing blood stasis, generating semen and benefiting marrow, improving the microcirculation in bones, activating regeneration factor of bone cells and improving immunocompetence of the body. The drug is used to treat rheumatism, arthritis deformans, ankylosing spondylitis, femoral head necrosis, femoral head fracture, femoral head dislocation, osteomyelitis, bone cyst, nonunion, etc.
[Physical Properties] The drug is nanometer magnetism capsules; the content is dust color to dark brown powder with fragrant odor and sweet taste.
[Administration and Dosage] Orally, 3-5 pills each time, 2-3 times daily, or adheres to the instruction of the pharmacist.
[Specifications] 0.3g×90 pills/bottle
[Package] Packed and sealed in the plastic bottle with a spiral cover.
[Storage] Sealed, away from light and moisture.
[Validity Duration] 3 years
[Country of Origin] Switzerland (GMP standard/Approved by FDA)
[Type of Product] Biopreparate
[Import Ratification] j-20071226FDA-S060472
[Switzerland Patent Registration No.] s200712263218.X
[Development Unit] Switzerland Nova Pharmaceutical Industry Co., Ltd.
[Technical Guide and Sub-packing Organization in Asia] General Hospital for Bone Diseases Rehabilitation of Chinese Society of Medical Immunology |